This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Thymosin alpha1 may serve as a therapeutic agent for lung infections by balancing immune responses.
Why it matters
Understanding how thymosin alpha1 works could lead to new therapies for lung infections, which remain a significant health threat. This research could improve patient outcomes in future respiratory outbreaks.
How the study worked
This is a review article that synthesizes recent findings on thymosin alpha1 and its role in immune regulation during lung infections.
What this study cannot tell us
As a review, it does not present original experimental data and relies on existing literature, which may vary in quality.
Read the original research
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.
International immunopharmacology, 117, 109949
Citation
Bellet, Marina M; Renga, Giorgia; Pariano, Marilena; Stincardini, Claudia; D'Onofrio, Fiorella; Goldstein, Allan L; Garaci, Enrico; Romani, Luigina; Costantini, Claudio. (2023). COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.. International immunopharmacology, 117, 109949. https://doi.org/10.1016/j.intimp.2023.109949